MIST Milestone Pharmaceuticals Inc.
Healthcare$1.40-0.71%ClosedMarket Cap: $120.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.10
P/S
67.88
EV/EBITDA
-2.97
DCF Value
$0.15
FCF Yield
-42.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
94.7%
Operating Margin
-3669.4%
Net Margin
-3832.0%
ROE
-339.4%
ROA
-35.3%
ROIC
-37.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $238.0K | 70.6% | $-23.8M | $-26.1M | $— | — |
| Q4 null | $1.5M | 100.0% | $-17.3M | $-17.4M | $— | — |
| FY null | $1.5M | 92.6% | $-62.5M | $-63.1M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-11.9M | $-11.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-12.5M | $-13.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-20.5M | $-20.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-12.3M | $-12.4M | $— | — |
| FY null | $0.00 | NaN% | $-42.1M | $-41.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-9.6M | $-9.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-9.7M | $-9.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-10.5M | $-10.4M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-13.9M | $-13.6M | $-0.41 | — |